Mazzariello Gina 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Aug 14, 2025
Insider Transaction Report
Form 4
Mazzariello Gina
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-08-12$8.07/sh−15,000$121,102→ 171,969 total - Sale
Common Stock
2025-08-13$8.34/sh−15,000$125,046→ 156,969 total
Footnotes (3)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.82 to $8.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.13 to $8.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.